Cannbiorx Life Sciences Stock Gross Profit
| ATNFW Stock | USD 0.01 0.0007 6.14% |
Fundamental analysis of CannBioRx Life allows traders to better anticipate movements in CannBioRx Life's stock price by examining its financial health and performance throughout various phases of its business cycle.
CannBioRx | Build AI portfolio with CannBioRx Stock |
CannBioRx Life Sciences Company Gross Profit Analysis
CannBioRx Life's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, CannBioRx Life Sciences reported 0.0 of gross profit. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
CannBioRx Fundamentals
| Return On Equity | -3.71 | ||||
| Return On Asset | -0.55 | ||||
| Number Of Shares Shorted | 23.3 K | ||||
| EBITDA | (6.32 M) | ||||
| Net Income | (6.17 M) | ||||
| Total Debt | 154.5 K | ||||
| Book Value Per Share | 0.89 X | ||||
| Cash Flow From Operations | (1.48 M) | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 250.78 M | ||||
| Total Asset | 12.76 M | ||||
| Retained Earnings | (141.52 M) | ||||
| Working Capital | 1.64 M | ||||
| Net Asset | 12.76 M |
About CannBioRx Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CannBioRx Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannBioRx Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannBioRx Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.